Hospitalization costs of TAVI in one Belgian university hospital

Acta Cardiologica

Volumn 68, Issue 3, 2013, Pages 263-270

  Van Gestel, Raf ^a   De Graeve, Diana ^a   Vrints, Christiaan ^b   Rodrigus, Inez ^b   Bosmans, Johan ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Belgium; Cost analysis; Hospitalization; Tavi

Indexed keywords

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; LEARNING CURVE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PULMONARY HYPERTENSION; QUALITY OF LIFE; RETROSPECTIVE STUDY; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNIVERSITY HOSPITAL; AORTA VALVE STENOSIS; BELGIUM; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; HOSPITAL CHARGE; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; REGISTER; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BELGIUM; CARDIAC CATHETERIZATION; COST-BENEFIT ANALYSIS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL CHARGES; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES;

MLCS; MLOWN;

EID: 84879571745     PISSN: 00015385     EISSN: 03737934     Source Type: Journal    
DOI: 10.1080/ac.68.3.2983420     Document Type: Article

References (15)

1. Leon MB, Smith CR, Mack M, Miller C, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-607.
2. Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P, Palmer S, Busca R, Sculpher M. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012; 98: 370-6.
3. Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O'Neill W, Davidson CJ, Smith CR, Leon MB, Cohen DJ. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 2012; 125: 1102-9.
4. Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012; 2: e001032.
5. Backx P. Artsenkrant, Terugbetaling voor 30 percutane hartkleppen. 2012. Last accessed December 18 2012. Available from: http://www.artsenkrant.com/nuxeo/site/ak/ (only available to subscribers).
6. Cribier A. Development of transcatheter aortic valve implantation (TAVI): A 20-year odyssey. Arch Cardiovasc Dis 2012; 105; 146-52.
7. Neyt M, Van Brabandt H, Van de Sande S, De Vriese S. Health Technology Assessment. Transcatheter Aortic Valve Implantation (TAVI): A Health Technology Assessment Update. Health Technology Assessment (HTA). Brussels: Belgian Health Care Knowledge Centre (KCE), KCE reports 163C, 2011, [http://kce.fgov.be/sites/default/files/page_documents/kce_163c_tavi_update.pdf].
8. College Voor Zorgverzekeringen. Transcatheter aortic valve replacement. 2011. Last accessed December 18 2012 [article in Dutch]. Available from: http://www.cvz.nl/binaries/live/cvzinternet/hst_content/nl/documenten/standpunten/2011/sp1110-transcatheteraortaklepvervanging-v3b.pdf.
9. Piazza N. TAVR Use Patterns on the European Continent: Growth, Penetration, and Reimbursement, [presentation] TCT conference; 2012 October 22-26; Miami, FL. Piazza N. Available from: http://dallasleipzigvalve.org/uploads/documents/Thursday%20Presentations/Penetration.pdf.
10. Bates MGD, Matthews IG, Fazal IA, Turley AJ. Postoperative permanent pacemaker implantation in patients undergoing trans-catheter aortic valve implantation: what is the incidence and are there any predicting factors? Interact Cardiovasc Thorac Surg 2011; 12: 243-53.
11. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder AJ, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali SS, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde JC, Hildick-Smith D. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011; 123: 951-60.
12. Bartoli S, Saia F, Marrozzini C, Berti E, Guastaroba P, Fortuna D, Ciuca C, Moretti C, Marzocchi A, De Palma R. The cost of innovation in treating aortic stenosis: transcatheter aortic valve implantation. G Ital Cardiol 2012; 13: 50-8 [article in Italian].
13. Gurvitch R, Tay EL, Wijesinghe N, Ye J, Nietlispach F, Wood DA, Lichtenstein S, Cheung A, Webb JG. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv 78: 977-84.
14. Alli OO, Booker JD, Lennon RJ, Greason KL, Rihal CS, Holmes DR. Transcatheter aortic valve implantation: assessing the learning curve. JACC Cardiovasc Interv 2012; 5: 72-9.
15. Cleemput I, Neyt M, Van de Sande S, Thiry N. Belgian guidelines for economic evaluations and budget impact analyses: second edition. Brussels: Belgian Health Care Knowledge Centre. KCE reports 183C, 2012. Available from: https://kce.fgov.be/publication/report/belgian-guidelines-for-economic-evaluationsand-budget-impact-analyses-second-edi.